• Fennec Pharmaceuticals director Rosty Raykov reported a net increase in common-share ownership to 130,079 shares.
• Raykov exercised stock options for 15,597 shares at USD 2.45 on June 1.
• He sold 9,747 common shares at USD 9.62 on June 1 to cover taxes tied to the option exercise.
• He also received 2,778 common shares at no cost on May 31 from the release of restricted shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468316-26-000015), on June 02, 2026, and is solely responsible for the information contained therein.